• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2013 Fiscal Year Final Research Report

Development of novel PSGL-1 targeted agents for metabolic syndrome

Research Project

  • PDF
Project/Area Number 24790927
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Metabolomics
Research InstitutionOkayama University

Principal Investigator

HORIGUCHI Chikage (佐藤 千景)  岡山大学, 医学部, 客員研究員 (40535192)

Project Period (FY) 2012-04-01 – 2014-03-31
Keywordsメタボリックシンドローム / PSGL-1 / 接着分子 / 内臓脂肪 / インスリン抵抗性
Research Abstract

Anti-PSGL-1 antibodies inhibited adipocyte hypertrophy and inflammation in white adipose tissue, and then ameliorated insulin resistance in type 2 diabetic mice. We separated and purified Fucoidan as a type of sulfated polysaccharides according to molecular weight. We are studying inhibition effects of each purified substances by using of monocytes-to-endothelial cells adhesion assay in vitro. We are going to determine the most effective substances for inhibiting cell adhesion, and then administer them to type 2 diabetic mice and study insulin resistance.

  • Research Products

    (18 results)

All 2014 2013 2012

All Journal Article (8 results) (of which Peer Reviewed: 8 results) Presentation (9 results) Book (1 results)

  • [Journal Article] Nuclear hormone receptor expression in mouse kidney and renal cell lines2014

    • Author(s)
      Ogawa D, Eguchi J, Wada J, Terami N, Hatanaka T, Tachibana H, Nakatsuka A, Horiguchi CS, Nishii N, Makino H
    • Journal Title

      PLoS One

      Volume: 9(1) Pages: e85594

    • DOI

      10.1371/journal.pone.0085594

    • Peer Reviewed
  • [Journal Article] Metallothionein deficiency exacerbates diabetic nephropathy in streptozotocin-induced diabetic mice2014

    • Author(s)
      Tachibana H, Ogawa D, Sogawa N, Asanuma M, Miyazaki I, Terami N, Hatanaka T, Horiguchi CS, Nakatsuka A, Eguchi J, Wada J, Yamada H, Takei K, Makino H
    • Journal Title

      Am J Physiol Renal Physiol

      Volume: 306(1) Pages: F105-15

    • DOI

      10.1152/ajprenal.00034

    • Peer Reviewed
  • [Journal Article] The effects of telmisartan treatment on the abdominal fat depot in patients with metabolic syndrome and essential hypertension : Abdominal fat Depot Intervention Program of Okayama (ADIPO)2013

    • Author(s)
      Murakami K, Wada J, Ogawa D, Horiguchi CS, Miyoshi T, Sasaki M, Uchida HA, Nakamura Y, Makino H
    • Journal Title

      Diab Vasc Dis Res

      Volume: 10(1) Pages: 93-6

    • DOI

      10.1177/1479164112444640

    • Peer Reviewed
  • [Journal Article] Telmisartan attenuates diabetic nephropathy by suppressing oxidative stress in db/db mice2013

    • Author(s)
      Sato-Horiguchi C, Ogawa D, Wada J, Tachibana H, Kodera R, Eguchi J, Nakatsuka A, Terami N, Shikata K, Makino H
    • Journal Title

      Nephron Exp Nephrol

      Volume: 121(3-4) Pages: e97-e108

    • DOI

      10.1159/000343102

    • Peer Reviewed
  • [Journal Article] Case of emphysematous cholecystitis in a patient with type 2 diabetes mellitus associated with schizophrenia2012

    • Author(s)
      Ogawa A, Shikata K, Uchida HA, Shinoura S, Yokomichi N, Ogawa D, Sato-Horiguchi C, Yagi T, Wada J, Makino H
    • Journal Title

      J Diabetes Invest

      Volume: 3(6) Pages: 534-535

    • Peer Reviewed
  • [Journal Article] Activation of liver X receptor inhibits osteopontin and ameliorates diabetic nephropathy2012

    • Author(s)
      Tachibana H, Ogawa D, Matsushita Y, Bruemmer D, Wada J, Teshigawara S, Eguchi J, Sato-Horiguchi C, Uchida HA, Shikata K, Makino H
    • Journal Title

      J Am Soc Nephrol

      Volume: 23(11) Pages: 1835-46

    • DOI

      10.1681/ASN.2012010022

    • Peer Reviewed
  • [Journal Article] Vaspin is an adipokine ameliorating ER stress in obesity as a ligand for cell-surface GRP78/MTJ-1 complex2012

    • Author(s)
      Nakatsuka A, Wada J, Iseda I, Teshigawara S, Higashio K, Murakami K, Kanzaki M, Inoue K, Terami T, Katayama A, Hida K, Eguchi J, Horiguchi CS, Ogawa D, Matsuki Y, Hiramatsu R, Yagita H, Kakuta S, Iwakura Y, Makino H
    • Journal Title

      Diabetes

      Volume: 61(11) Pages: 2823-32

    • DOI

      10.2337/db12-0232

    • Peer Reviewed
  • [Journal Article] Cholecystokinin plays a novel protective role in diabetic kidney through anti-inflammatory actions on macrophage : anti-inflammatory effect of cholecystokinin2012

    • Author(s)
      Miyamoto S, Shikata K, Miyasaka K, Okada S, Sasaki M, Kodera R, Hirota D, Kajitani N, Takatsuka T, Kataoka HU, Nishishita S, Sato C, Funakoshi A, Nishimori H, Uchida HA, Ogawa D, Makino H
    • Journal Title

      Diabetes

      Volume: 61(4) Pages: 897-907

    • DOI

      10.2337/db11-0402

    • Peer Reviewed
  • [Presentation] 糖尿病マウス腎および高糖濃度刺激下での培養腎細胞における核内受容体の発現解析2013

    • Author(s)
      寺見直人, 小川大輔, 堀口千景, 他
    • Organizer
      第56回日本糖尿病学会年次学術集会
    • Place of Presentation
      熊本(熊本市現代美術館)
    • Year and Date
      2013-05-17
  • [Presentation] 2型糖尿病における腎症の寛解および改善に関与する因子の解析2013

    • Author(s)
      小野哲一郎, 四方賢一, 堀口千景, 他
    • Organizer
      第56回日本糖尿病学会年次学術集会
    • Place of Presentation
      熊本(熊本公徳会武道場)
    • Year and Date
      2013-05-16
  • [Presentation] Liver X receptor agonist ameliorates diabetic nephropathy by inhibiting high glucose-induced osteopontin expression in proximal tubular epithelial cells2012

    • Author(s)
      Ogawa D, Tachibana H, Sato-Horiguchi C, et al
    • Organizer
      AHA Scientific Sessions 2012
    • Place of Presentation
      San Diego, California, USA
    • Year and Date
      20121103-07
  • [Presentation] 早期糖尿病性腎症におけるTelmisartan の抗酸化作用の検討2012

    • Author(s)
      堀口 千景, 他
    • Organizer
      第27回日本糖尿病合併症学会
    • Place of Presentation
      福岡(アクロス福岡)
    • Year and Date
      20121102-03
  • [Presentation] Liver X receptor agonist ameliorates diabetic nephropathy by inhibiting high glucose-induced osteopontin expression in proximal tubular epithelial cells2012

    • Author(s)
      Ogawa D, Tachibana H, Sato-Horiguchi C, et al
    • Organizer
      ASN kidney Week 2012
    • Place of Presentation
      San Diego, USA
    • Year and Date
      20121030-1104
  • [Presentation] Inhibition of PSGL-1 ameliorates obesity-related insulin resistance by prevention of inflammation in adipose tissue and liver in db/db mice2012

    • Author(s)
      Daisho Hirota, Chikage Sato, et al
    • Organizer
      EASD 48th Annual Meeting
    • Place of Presentation
      Berlin, Germany
    • Year and Date
      20121001-05
  • [Presentation] 早期糖尿病性腎症におけるTelmisartan の抗酸化作用の検討2012

    • Author(s)
      佐藤 千景, 他
    • Organizer
      第55回日本糖尿病学会年次学術集会
    • Place of Presentation
      横浜(パシフィコ横浜)
    • Year and Date
      20120517-19
  • [Presentation] PSGL-1 を阻害することにより, 肥満マウスにおける内臓脂肪と肝臓の炎症とインスリン抵抗性が抑制される2012

    • Author(s)
      廣田 大昌, 佐藤 千景, 他
    • Organizer
      第55回日本糖尿病学会年次学術集会
    • Place of Presentation
      横浜(パシフィコ横浜)
    • Year and Date
      20120517-19
  • [Presentation] 糖尿病性腎症モデルラットにおけるメタロチオネイン(metallothionein)の発現の検討2012

    • Author(s)
      橘 洋美, 佐藤 千景, 他
    • Organizer
      第55回日本糖尿病学会年次学術集会
    • Place of Presentation
      横浜(パシフィコ横浜)
    • Year and Date
      20120517-19
  • [Book] 糖尿病×CKD 診療ガイド Q&A2012

    • Author(s)
      堀口 千景
    • Total Pages
      61-63(179)
    • Publisher
      南山堂

URL: 

Published: 2015-06-25   Modified: 2015-07-14  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi